#$%^&*AU2020201161A120200305.pdf#####ABSTRACT Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti- TGF- 1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically. 1